Bioinformatics Analysis and Experimental Validation Reveal That CDC20 Overexpression Promotes Bladder Cancer Progression and Potential Underlying Mechanisms

Overview

Journal Genes Genomics

Specialty Genetics

Date 2024 Mar 4

PMID 38438666

Authors

Yuan Liu

Shao-Hui Zou

Xin Gao

Affiliations

Soon will be listed here.

Abstract

Background: Bladder cancer is a prevalent malignancy. CDC20, a pivotal cell cycle regulator gene, plays a significant role in tumour cell proliferation, but its role in bladder cancer remains unclear.

Objective: This study aimed to analyse CDC20 expression in bladder cancer and explore its roles in tumour progression, treatment response, patient prognosis, and cellular proliferation mechanisms.

Methods: We systematically analysed CDC20 expression in bladder cancer using bioinformatics. Our study investigated the impact of CDC20 on chemotherapy and radiotherapy sensitivity, patient prognosis, and changes in CDC20 methylation levels. We also explored the role and potential underlying mechanisms of CDC20 in bladder cancer cell growth. We used lentiviral transfection to downregulate CDC20 expression in 5637 and T24 cells, followed by CCK-8, colony formation, scratch, invasion, apoptosis, and cell cycle analyses.

Results: CDC20 is highly expressed in bladder cancer and is significantly correlated with poor prognosis. Moreover, CDC20 demonstrated high diagnostic potential for bladder cancer (AUC > 0.9). The tumour methylation levels of CDC20 in tumour tissues markedly decreased compared with those in normal tissues, and lower methylation levels were associated with a worse prognosis. Elevated CDC20 expression is linked to increased mutation burden. Our findings suggested a potential association between high CDC20 expression and resistance to chemotherapy and radiotherapy, as CDC20 expression may impact immune cell infiltration levels. Mechanistic analysis revealed the influence of CDC20 on bladder cancer cell proliferation through cell cycle-related pathways. According to the cell experiments, CDC20 downregulation significantly impedes bladder cancer cell proliferation and invasion, leading to G1 phase arrest.

Conclusion: Aberrantly high CDC20 expression promotes tumour progression in bladder cancer, resulting in a poor prognosis, and may also constitute a promising therapeutic target.

Citing Articles

Impact of potential biomarkers, SNRPE, COX7C, and RPS27, on idiopathic Parkinson's disease.

Cheon J, Jung H, Kang B, Kim M Genes Genomics. 2024; 47(1):47-57.

PMID: 39467967 DOI: 10.1007/s13258-024-01591-x.

References

Chen Y, Wang S, Huang S, Su C, Liu P, Cheng W . Protodioscin inhibits bladder cancer cell migration and growth, and promotes apoptosis through activating JNK and p38 signaling pathways. Biomed Pharmacother. 2022; 156:113929. DOI: 10.1016/j.biopha.2022.113929. View

Choi J, Kim Y, Lee J, Kim Y . High expression of spindle assembly checkpoint proteins CDC20 and MAD2 is associated with poor prognosis in urothelial bladder cancer. Virchows Arch. 2013; 463(5):681-7. DOI: 10.1007/s00428-013-1473-6. View

Cockrell D, Rose T . Current Status of Perioperative Therapy in Muscle-Invasive Bladder Cancer and Future Directions. Curr Oncol Rep. 2023; 25(5):511-520. DOI: 10.1007/s11912-023-01390-9. View

Fernandez M, Brausi M, Clark P, Cookson M, Grossman H, Khochikar M . Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD-SIU joint consultation on bladder cancer. World J Urol. 2018; 37(1):3-13. DOI: 10.1007/s00345-018-2436-y. View

Gonzalez M, Li F . DNA replication, RNAi and epigenetic inheritance. Epigenetics. 2011; 7(1):14-9. PMC: 3329497. DOI: 10.4161/epi.7.1.18545. View

He W, Meng J . CDC20: a novel therapeutic target in cancer. Am J Transl Res. 2023; 15(2):678-693. PMC: 10006751. View

Jeong S, Bui Q, Kwak M, Lee J, Lee P . Targeting Cdc20 for cancer therapy. Biochim Biophys Acta Rev Cancer. 2022; 1877(6):188824. DOI: 10.1016/j.bbcan.2022.188824. View

Kidokoro T, Tanikawa C, Furukawa Y, Katagiri T, Nakamura Y, Matsuda K . CDC20, a potential cancer therapeutic target, is negatively regulated by p53. Oncogene. 2007; 27(11):1562-71. DOI: 10.1038/sj.onc.1210799. View

Li W, Chen H, Wang Z, Liu J, Lei X, Chen W . Chromobox 4 (CBX4) promotes tumor progression and stemness via activating CDC20 in gastric cancer. J Gastrointest Oncol. 2022; 13(3):1058-1072. PMC: 9274029. DOI: 10.21037/jgo-22-549. View

10.

Li J, Qi Y, Li B, Liu Y, Yang K, Zhang Z . STIL/AURKA axis promotes cell proliferation by influencing primary cilia formation in bladder cancer. J Transl Med. 2023; 21(1):281. PMC: 10131372. DOI: 10.1186/s12967-023-04118-2. View

11.

Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka S . Epidemiology, Screening, and Prevention of Bladder Cancer. Eur Urol Oncol. 2022; 5(6):628-639. DOI: 10.1016/j.euo.2022.10.003. View

12.

Mari A, DAndrea D, Abufaraj M, Foerster B, Kimura S, Shariat S . Genetic determinants for chemo- and radiotherapy resistance in bladder cancer. Transl Androl Urol. 2018; 6(6):1081-1089. PMC: 5760393. DOI: 10.21037/tau.2017.08.19. View

13.

Sevim Nalkiran H, Akcora Yildiz D, Saydam F, Guzel A, Nalkiran I . Targeting the anaphase-promoting complex/cyclosome (APC/C) enhanced antiproliferative and apoptotic response in bladder cancer. Saudi J Biol Sci. 2023; 30(3):103564. PMC: 9923226. DOI: 10.1016/j.sjbs.2023.103564. View

14.

Shi M, Dai W, Jia R, Zhang Q, Wei J, Wang Y . APC-mediated degradation of PHD3 stabilizes HIF-1a and promotes tumorigenesis in hepatocellular carcinoma. Cancer Lett. 2020; 496:144-155. DOI: 10.1016/j.canlet.2020.10.011. View

15.

Siegel R, Miller K, Fuchs H, Jemal A . Cancer statistics, 2022. CA Cancer J Clin. 2022; 72(1):7-33. DOI: 10.3322/caac.21708. View

16.

Wang L, Zhang J, Wan L, Zhou X, Wang Z, Wei W . Targeting Cdc20 as a novel cancer therapeutic strategy. Pharmacol Ther. 2015; 151:141-51. PMC: 4457591. DOI: 10.1016/j.pharmthera.2015.04.002. View

17.

Wang J, Yang S, Ji Q, Li Q, Zhou F, Li Y . Long Non-coding RNA EPIC1 Promotes Cell Proliferation and Motility and Drug Resistance in Glioma. Mol Ther Oncolytics. 2020; 17:130-137. PMC: 7163045. DOI: 10.1016/j.omto.2020.03.011. View

18.

Wang L, Yang C, Chu M, Wang Z, Xue B . Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation. Cancer Lett. 2020; 500:172-181. DOI: 10.1016/j.canlet.2020.11.052. View

19.

Wang N, Chen Y, Wu J . CCT6A is associated with CDC20, Enneking stage and prognosis in osteosarcoma, and its knockdown suppresses osteosarcoma cell viability and invasion. Oncol Lett. 2023; 25(5):201. PMC: 10126619. DOI: 10.3892/ol.2023.13787. View

20.

Weinstein J, Jacobsen F, Wu T, Baum L . A novel mammalian protein, p55CDC, present in dividing cells is associated with protein kinase activity and has homology to the Saccharomyces cerevisiae cell division cycle proteins Cdc20 and Cdc4. Mol Cell Biol. 1994; 14(5):3350-63. PMC: 358701. DOI: 10.1128/mcb.14.5.3350-3363.1994. View